Your browser doesn't support javascript.
loading
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.
Diamond, Jennifer R; Eckhardt, S G; Pitts, Todd M; van Bokhoven, Adrie; Aisner, Dara; Gustafson, Daniel L; Capasso, Anna; Sams, Sharon; Kabos, Peter; Zolman, Kathryn; Colvin, Tiffany; Elias, Anthony D; Storniolo, Anna M; Schneider, Bryan P; Gao, Dexiang; Tentler, John J; Borges, Virginia F; Miller, Kathy D.
Afiliação
  • Diamond JR; University of Colorado Cancer Center, Aurora, CO, USA. jennifer.diamond@ucdenver.edu.
  • Eckhardt SG; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, University of Colorado Cancer Center, 12801 East 17th Avenue, Mailstop 8117, Aurora, CO, 80045, USA. jennifer.diamond@ucdenver.edu.
  • Pitts TM; Department of Oncology, University of Texas at Austin, Dell Medical School, Austin, TX, USA.
  • van Bokhoven A; University of Colorado Cancer Center, Aurora, CO, USA.
  • Aisner D; University of Colorado Cancer Center, Aurora, CO, USA.
  • Gustafson DL; University of Colorado Cancer Center, Aurora, CO, USA.
  • Capasso A; University of Colorado Cancer Center, Aurora, CO, USA.
  • Sams S; Department of Oncology, University of Texas at Austin, Dell Medical School, Austin, TX, USA.
  • Kabos P; University of Colorado Cancer Center, Aurora, CO, USA.
  • Zolman K; University of Colorado Cancer Center, Aurora, CO, USA.
  • Colvin T; University of Colorado Cancer Center, Aurora, CO, USA.
  • Elias AD; University of Colorado Cancer Center, Aurora, CO, USA.
  • Storniolo AM; University of Colorado Cancer Center, Aurora, CO, USA.
  • Schneider BP; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.
  • Gao D; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.
  • Tentler JJ; University of Colorado Cancer Center, Aurora, CO, USA.
  • Borges VF; University of Colorado Cancer Center, Aurora, CO, USA.
  • Miller KD; University of Colorado Cancer Center, Aurora, CO, USA.
Breast Cancer Res ; 20(1): 82, 2018 08 02.
Article em En | MEDLINE | ID: mdl-30071865
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Neoplasias da Mama Masculina / Inibidores de Proteínas Quinases / Neoplasias de Mama Triplo Negativas / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Breast Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Neoplasias da Mama Masculina / Inibidores de Proteínas Quinases / Neoplasias de Mama Triplo Negativas / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Breast Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos